Search results
COPD patients see promise of new therapies to ease discomfort, aid breathing
United Press International via Yahoo News· 7 months agoRecent advances in chronic obstructive pulmonary disease offer patients more hope in easing...
The Most Exciting New Advances in Managing COPD
Time via Yahoo News· 1 month agoCredit - Karl Tapales—Getty Images The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and...
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Motley Fool· 12 months agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2023 Earnings Call Apr 27, 2023, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoVerona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript February 29, 2024 Verona Pharma plc...
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
Benzinga via Yahoo Finance· 11 months agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) presented results from a...
2 Top Growth Stocks to Buy With $1,000 Right Now
Motley Fool via Yahoo Finance· 2 months agoThe healthcare industry has proved to be a remarkably resilient place for investors. Generally speaking, the kinds of products and services that...
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma, Inc. TBPH reported adjusted loss (excluding restructuring and related...
Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?
Motley Fool· 1 year agoOn March 23, Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) Dupixent shared positive results in...
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
Motley Fool via Yahoo Finance· 1 month agoEli Lilly has been on a roll. The big drugmaker won U.S. regulatory approval for weight loss drug...
